Back to Search
Start Over
Corrigendum to "Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT-EP)" [Lung Cancer 186 (2023) 107426].
- Source :
-
Lung Cancer (01695002) . Feb2024, Vol. 188, pN.PAG-N.PAG. 1p. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 01695002
- Volume :
- 188
- Database :
- Academic Search Index
- Journal :
- Lung Cancer (01695002)
- Publication Type :
- Academic Journal
- Accession number :
- 175136268
- Full Text :
- https://doi.org/10.1016/j.lungcan.2023.107450